It’s the depths of summer. It’s still stultifyingly, dangerously hot. Going outside is a fool’s game unless you have 500 SPF sunblock and a personal AC unit. Be sensible: Stay inside and enjoy some of ...

For someone whose office has a view of a carnival, Lonny Warner is decidedly unwhimsical. The CEO of Reddy Ice, the largest producer of packaged ice in North America, Warner is tall and broad in ...

If you’re a Verizon customer looking to get more value out of your mobile or home internet service, I’ve got news for you. There’s a solid slate of free and discounted streaming services that come ...

Washington — President Trump's media company will sell faster access to Truth Social posts, where the president often announces policy updates and market-moving news. Trump Media & Technology Group ...

Dr. Reddy's Laboratories has identified an impurity in a new scale-up batch of its Semaglutide Active Pharmaceutical Ingredient (API). This has led to a halt in commercial supply to its partner, ...

Dr. Reddy’s Laboratories Ltd. cut the first-year manufacturing target for its generic Ozempic drug as it paused commercial production until at least October after finding an unknown impurity in a key ...

Mumbai: Dr Reddy's Laboratories has halted the production and supply of its generic semaglutide injectable after identifying an impurity in the drug's active pharmaceutical ingredient (API) developed ...

Congo says Ebola outbreak spreads to northeastern Bas-Uele province Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Scientific model of the molecule semaglutide seen in Hellerup, Denmark, October 3, 2023. REUTERS/Ali Withers/File ...

Arre yaar, Dr. Reddy's ne apne semaglutide drug ki supply band kar di hai kyunki API (active pharmaceutical ingredient) mein quality ka issue mil gaya hai. Company keh rahi hai ki patient safety par ...

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the part of the drugmaker can take a toll. Case in point, Dr. Reddy’s share price ...

Reddy's says semaglutide API had an impurity issue, halts production of new batches Sees semaglutide supplies resuming in late October, early November Aims to sell 6-7 million semaglutide pens in ...